Keyphrases
Glucagon-like
100%
Receptor Agonist
100%
Agonist Treatment
100%
A1 Receptor
100%
Exendin-4 (Ex-4)
100%
Opioids
57%
Remifentanil
42%
Male Mice
28%
Opioid Addiction
28%
Nicotine
28%
Alcohol Effects
28%
Reinforcing Effect
28%
Rewarding Effect
14%
μ-opioid Receptor
14%
Conditioned Place Preference
14%
Rodents
14%
Public Health Risk
14%
Behavioral Effects
14%
Locomotor Activity
14%
Mouse Behavior
14%
Hyperlocomotion
14%
Peripheral Tissues
14%
Self-administration
14%
Food Intake
14%
Opioid Overdose
14%
Naltrexone
14%
Mechanism of Action
14%
Amphetamine
14%
Addiction
14%
Analgesia
14%
Female Mice
14%
Morphine
14%
Morphine Analgesia
14%
Central Stimulants
14%
Spontaneous Locomotor Activity
14%
Short-acting
14%
Cocaine
14%
Drug Class
14%
Gut Hormones
14%
Diabetes Medications
14%
Blood Glucose
14%
Neuropeptides
14%
Glucose Consumption
14%
Neuroscience
Glucagon-Like Peptide-1 Agonist
100%
Exenatide
100%
Glucagon
85%
Remifentanil
42%
Morphine
42%
Conditioned Place Preference
28%
Opioid Dependence
28%
Locomotor Activity
28%
Neuropeptide
14%
Behavioral Effect
14%
Receptor Agonists
14%
Analeptic
14%
Behavior (Neuroscience)
14%
Morphine Withdrawal
14%
Receptor
14%
Amphetamine
14%
Gastrointestinal Hormone
14%
Naltrexone
14%
Pharmacology, Toxicology and Pharmaceutical Science
Glucagon Like Peptide 1 Receptor Agonist
100%
Exendin 4
100%
Glucagon
85%
Morphine
57%
Remifentanil
42%
Ethanol
42%
Opiate Addiction
28%
Amphetamine
14%
Opioid Overdose
14%
Diseases
14%
Receptor Agonist
14%
Neuropeptide
14%
Receptor
14%
Behavioral Effect
14%
Gastrointestinal Hormone
14%
Stimulant
14%
Naltrexone
14%